Zentalis Pharmaceuticals
ZNTL
ZNTL
86 hedge funds and large institutions have $54.9M invested in Zentalis Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
86
Holding in Top 10
–
Calls
$27K
Puts
–
Top Buyers
| 1 | +$5.03M | |
| 2 | +$1.58M | |
| 3 | +$813K | |
| 4 |
Barclays
London,
United Kingdom
|
+$592K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$591K |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$2.34M | |
| 3 | -$1.79M | |
| 4 |
Morgan Stanley
New York
|
-$879K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$838K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CA
101
Clearstead Advisors
Cleveland,
Ohio
| – |
|
|||
102
Citigroup
New York
| – |
|
|||
|
IA
103
IFP Advisors
Tampa,
Florida
| – |
|
|||
|
C
104
Covestor
London,
United Kingdom
| – |
|